Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis: study protocol for a randomised controlled trial (CRAMMS).
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications.
The role of optical coherence tomography (OCT) in optic neuritis (ON).
Lack of association between CD226 genetic variants and inflammatory demyelinating diseases in Korean population.
Multiple sclerosis.
Neuroimmunology: Aquaporin-4-antibody-seronegative neuromyelitis optica is less common than previously thought.
Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies.
Teriflunomide and its mechanism of action in multiple sclerosis.
The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review.
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications.
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Biological monitoring of IFN-β therapy in Multiple Sclerosis.

Pages